Tiziana Life Sciences Ltd • TLSA

Capital at risk.

About Tiziana Life Sciences Ltd
Ticker
info
TLSA
Trading on
info
NASDAQ
ISIN
info
BMG889121031
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Ivor R. Elrifi Ph.D.
Headquarters
info
14/15 Conduit Street, London, undefined, United Kingdom, W1S 2XJ
Employees
info
9
Website
info
tizianalifesciences.com
Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for use in the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It is also developing TZLS-501, a fully human mAb targeting the IL-6 receptor for use in the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.
Metrics
BasicAdvanced
Market cap
info
$208M
P/E ratio
info
-
EPS
info
-$0.12
Dividend Yield
info
0.00%
Beta
info
0.22
Forward P/E ratio
info
0
EBIDTA
info
$-18.5M
Ex dividend date
info
-
Price & volume
Market cap
info
$208M
Average daily volume
info
0.2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
22.6
Earnings
EPS
info
-$0.12
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-18.5M
Revenues (TTM)
info
$-3.6M
Revenues per share (TTM)
info
-$0.02
Technicals
Beta
info
0.22
52-week High
info
$2.60
52-week Low
info
$0.63
50-day moving average
info
$1.90
200-day moving average
info
$1.52
Short ratio
info
2.72
Short %
info
1.58%
Management effectiveness
ROE (TTM)
info
-232.31%
ROA (TTM)
info
-83.78%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
119M
Float
info
63.9M
Insiders %
info
46.12%
Institutions %
info
3.91%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.06
-$0.06
-
Q1 • 22Beat
-$0.06
-
-
Q3 • 22Beat
-$0.05
-
-
Q3 • 24Beat
-$0.07
-
-
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$-9.3M
0.00%
Q2 • 24
$-7.2M
0.00%
Q1 • 25
NaN%
-22.55%
0.00%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$11.3M
$7.3M
65.12%
Q4 • 24
$11.3M
$7.3M
65.12%
Q1 • 25
0.00%
0.00%
0.00%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-1.5M
-
$3.7M
$-1.5M
Q4 • 24
$-1.9M
-
$4.6M
$-1.9M
Q1 • 25
25.14%
-
25.14%
25.14%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Tiziana Life Sciences Ltd share?
Collapse

Tiziana Life Sciences Ltd shares are currently traded for undefined per share.

How many shares does Tiziana Life Sciences Ltd have?
Collapse

Tiziana Life Sciences Ltd currently has 119M shares.

Does Tiziana Life Sciences Ltd pay dividends?
Collapse

No, Tiziana Life Sciences Ltd doesn't pay dividends.

What is Tiziana Life Sciences Ltd 52 week high?
Collapse

Tiziana Life Sciences Ltd 52 week high is $2.60.

What is Tiziana Life Sciences Ltd 52 week low?
Collapse

Tiziana Life Sciences Ltd 52 week low is $0.63.

What is the 200-day moving average of Tiziana Life Sciences Ltd?
Collapse

Tiziana Life Sciences Ltd 200-day moving average is $1.52.

Who is Tiziana Life Sciences Ltd CEO?
Collapse

The CEO of Tiziana Life Sciences Ltd is Dr. Ivor R. Elrifi Ph.D..

How many employees Tiziana Life Sciences Ltd has?
Collapse

Tiziana Life Sciences Ltd has 9 employees.

What is the market cap of Tiziana Life Sciences Ltd?
Collapse

The market cap of Tiziana Life Sciences Ltd is $208M.

What is the P/E of Tiziana Life Sciences Ltd?
Collapse

The current P/E of Tiziana Life Sciences Ltd is null.

What is the EPS of Tiziana Life Sciences Ltd?
Collapse

The EPS of Tiziana Life Sciences Ltd is -$0.12.

What is the PEG Ratio of Tiziana Life Sciences Ltd?
Collapse

The PEG Ratio of Tiziana Life Sciences Ltd is null.